Study of Telitacicept for Eye Muscle Weakness from Myasthenia Gravis
Treatments studied
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This trial tests a new drug, telitacicept, for people with myasthenia gravis that only affects the eyes (ocular myasthenia gravis). The goal is to see if it can improve symptoms like droopy eyelids or double vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 80 years old.
- You weigh at least 30 kg (about 66 pounds).
- You have been diagnosed with myasthenia gravis that only affects your eyes (MGFA Type I).
- You are on a stable treatment plan for your condition.
- You do not have other uncontrolled medical conditions or infections.
- You are not allergic to human-derived biologic medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug (EA5) injected under the skin or into a vein for people with a specific form of myasthenia gravis (caused by AChR antibodies). The goal is to find the safest dose and see how well it may reduce muscle weakness.
This trial tests whether tocilizumab can improve symptoms and safety in people with generalized myasthenia gravis (MG) who already take standard MG treatments. It may help if your weakness is still significant despite current therapy.
This trial is testing a new medication called telitacicept to see if it can help children with eye muscle weakness from myasthenia gravis. It aims to find a more effective and safe treatment for this condition, which can affect vision and daily activities.
This trial tests a new drug called telitacicept combined with low-dose steroids for people with myasthenia gravis that hasn't improved with standard treatments. It aims to reduce muscle weakness and improve daily function.
This trial tests an investigational drug called telitacicept for people with inflammatory myopathy (muscle inflammation). It may help reduce muscle weakness and other symptoms when standard treatments haven't worked well enough.
This study tests a new combination treatment for generalized myasthenia gravis. It combines two medications to help reduce muscle weakness and improve your daily life.
Hear when a new Myasthenia Gravis, Ocular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.